Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH

Biopsy-proven NAFLD patients with significant fibrosis were at risk of developing type 2 diabetes mellitus and arterial hypertension. The risk of metabolic outcomes in patients with significant fibrosis was increased in presence of obesity. Additionally to the liver biopsy, patients with intermediate-to-high risk of significant fibrosis by Hepamet Fibrosis Score were at risk of type 2 diabetes mellitus.

Source: Journal of Hepatology - March 4, 2020 Category: Gastroenterology Authors: Javier Ampuero, Roc ío Aller, Rocío Gallego-Durán, Javier Crespo, José Luis Calleja, Carmelo García-Monzón, Judith Gómez-Camarero, Joan Caballería, Oreste Lo Iacono, Luis Ibañez, Javier García-Samaniego, Agustín Albillos, Rubén Francés, Conra Source Type: research